Search clinical trials for: XC130-A10H

Total 80 results

Xoc Pharmaceuticals
Celerion

Active, not recruiting

Single Ascending Dose Study Investigating the Safety, Tolerability, and PK of XC130-A10H in Healthy Adult Subjects

Parkinson's Disease

United States
Canadian Network for Observational Drug Effect...
Canadian Institutes of Health Research (CIHR); Drug Safety and Effectiveness...

Completed

Safety of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Among Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetic Ketoacidosis | Lower Extremity Amputation | Urosepsis

Canada
Burzynski Research Institute

Completed

Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Mixed Gliomas

Mixed Gliomas

United States
Institut Paoli-Calmettes

Completed

Phase I/II Study of Immune Therapy After Allograft in Patients With Myeloid Hemopathy (ALLO-WT1)

Acute Myeloid Leukemia | Chronic Myeloid Leukemia | Myelodysplastic Syndrome

France
Baxter Healthcare Corporation
Gambro Renal Products, Inc.

Completed

Molecule Removal and Ease of Use: A Comparison of Two Different Dialyzers

Chronic Kidney Disease

United States
Adaptimmune

Completed

MAGE-A10ᶜ⁷⁹⁶T for Urothelial Cancer, Melanoma or Head and Neck Cancers

Melanoma | Head and Neck Cancer | Urothelial Carcinoma | Bladder Urothelial Carcinoma

United States, Canada, Spain
Nipro Europe N.V.

Completed

In Vivo Evaluation of the Nipro Elisio™ Dialyzer

Chronic Kidney Disease

France
Ruijin Hospital
RenJi Hospital

Unknown

Continuous Blood Purification for Regulation of Early Inflammatory Response In Severe Acute Pancreatitis

Acute Pancreatitis

China
University of Michigan
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy

Nonalcoholic Steatohepatitis | Lipodystrophy | Fatty Liver Disease, Nonalcoholic

United States
Burzynski Research Institute

Completed

Antineoplaston Therapy in Treating Children With Low-Grade Astrocytoma

Low Grade Astrocytomas

United States
Burzynski Research Institute

Terminated

Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma

Malignant Mesothelioma

United States
Burzynski Research Institute

Terminated

Antineoplaston Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer

Stage IV Non-small Cell Lung Cancer

United States
Burzynski Research Institute

Terminated

Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer

Stage IV Ovarian Cancer | Stage III Ovarian Cancer

United States
Burzynski Research Institute

Terminated

Antineoplaston Therapy in Treating Patients With Cancer of the Small Intestine

Small Intestine Cancer

United States
Burzynski Research Institute

Terminated

Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Neuroblastoma

Neuroblastoma

United States
Burzynski Research Institute

Completed

Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors

Malignant Brain Tumors

United States
Burzynski Research Institute

Terminated

Antineoplaston Therapy in Treating Patients With Meningioma

Meningioma

United States
Burzynski Research Institute

Not yet recruiting

Study of Antineoplaston Therapy + Radiation vs. Radiation Only in Diffuse, Intrinsic, Brainstem Glioma (DIPG)

Brain Stem Glioma
Burzynski Research Institute

Not yet recruiting

Effect of Antineoplaston Therapy on the QT/QTc Interval In Subjects With Diffuse, Intrinsic, Brainstem Glioma (DBSG)

Brain Stem Glioma
Burzynski Research Institute

Terminated

Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary Origin

Unknown Primary Carcinoma

United States
Burzynski Research Institute

Terminated

Antineoplaston Therapy in Treating Patients With Metastatic Prostate Cancer

Metastatic Prostate Cancer

United States
Burzynski Research Institute

Terminated

Antineoplaston Therapy in Treating Patients With Multiple Myeloma

Multiple Myeloma

United States
Burzynski Research Institute

Terminated

Antineoplaston Therapy in Treating Patients With Cancer of the Esophagus

Adenocarcinoma of the Esophagus

United States
Burzynski Research Institute

Terminated

Antineoplaston Therapy in Treating Patients With Non-Hodgkin's Lymphoma

Non Hodgkin Lymphoma

United States
Burzynski Research Institute

Terminated

Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer

Stage IV Lung Cancer

United States
Burzynski Research Institute

Completed

Antineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma Multiforme

Glioblastoma Multiforme of Brain

United States
Burzynski Research Institute

Terminated

Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma

High Grade Glioma

United States
Burzynski Research Institute

Terminated

Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma

Oligodendroglioma, Adult

United States
Burzynski Research Institute

Terminated

Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer

Prostate Cancer

United States
Burzynski Research Institute

Withdrawn

Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Waldenstrom's Macroglobulinemia

Waldenstrom Macroglobulinemia

United States
Burzynski Research Institute

Terminated

Antineoplaston Therapy in Treating Patients With Stage IV Kidney Cancer

Stage IV Kidney Cancer

United States
Burzynski Research Institute

Terminated

Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer

Stage IV Lung Cancer

United States
Burzynski Research Institute

Terminated

Antineoplaston Therapy in Treating Patients With Stomach Cancer

Stomach (Gastric) Cancer

United States
Burzynski Research Institute

Terminated

Antineoplaston Therapy in Treating Patients With Soft Tissue Sarcoma

Soft Tissue Sarcoma

United States
Burzynski Research Institute

Terminated

Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Primitive Neuroectodermal Tumors

Primitive Neuroectodermal Tumor

United States
Burzynski Research Institute

Completed

Antineoplaston Therapy in Treating Adult Patients With Anaplastic Astrocytoma (AA)

Adult Brain Tumor

United States
Burzynski Research Institute

Terminated

Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors

Childhood Brain Tumor

United States
Burzynski Research Institute

Terminated

Antineoplaston Therapy in Treating Patients With Neurofibroma and Schwannoma

CNS Tumor

United States
Burzynski Research Institute

Suspended

A Study of Atengenal and Astugenal in Diffuse, Intrinsic Pontine Glioma (DIPG)

Diffuse, Intrinsic Pontine Glioma

United States
Burzynski Research Institute

Completed

Antineoplaston Therapy in Treating Children With Brain Tumors

Childhood Brain Tumors

United States
Burzynski Research Institute

Terminated

Antineoplaston Therapy in Treating Patients With Ependymoma

Ependymoma

United States
Burzynski Research Institute

Terminated

Antineoplaston Therapy in Treating Patients With Stage IV Melanoma

Stage IV Melanoma

United States
Burzynski Research Institute

Terminated

Antineoplaston Therapy in Treating Patients With Low-Grade Astrocytoma

Low-Grade Astrocytoma, Nos

United States
Burzynski Research Institute

Completed

Antineoplaston Therapy in Treating Adults With Residual/Recurrent/Progressive Glioblastoma Multiforme

Glioblastoma Multiforme of the Brain

United States
Burzynski Research Institute

Completed

Antineoplaston Therapy in Treating Patients With Brain Stem Glioma

Brain Stem Gliomas

United States
Burzynski Research Institute

Terminated

Antineoplaston Therapy in Treating Patients With High-Grade Stage II - Stage IV Non-Hodgkin's Lymphoma

Non-hodgkins Lymphoma

United States
Burzynski Research Institute

Terminated

Antineoplaston Therapy in Treating Patients With Intermediate-Grade Stage II - IV Non-Hodgkin's Lymphoma

Non-hodgkins Lymphoma

United States
Burzynski Research Institute

Terminated

Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer

Head and Neck Cancer

United States
Burzynski Research Institute

Terminated

Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva

Cervical Cancer Stage IV | Vulvar Cancer, Stage IV

United States
Burzynski Research Institute

Terminated

Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Bladder

Stage IV Bladder Cancer

United States

Search clinical trials for: XC130-A10H

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations